Table 1. Characteristicsofpatientswithrheumatoid arthritis(RA):Algiers(Algeria):2018-2019.
|
Data |
Outcome |
Unit/Category |
Total sample (n=59) |
ACPA - (n=33) |
ACPA + (n=26) |
p-value |
|
Sex |
(male) |
8 (13.6) |
4 (12.1) |
4 (15.4) |
0.7219 |
|
|
Age |
(year) |
59±14 |
63±13 |
53±12 |
0.0025 * |
|
|
Sex and anthropometric data |
Weight |
(kg) |
69±15 |
67±14 |
71±15 |
0.3244 |
|
Height |
(m) |
156±7 |
155±8 |
158±6 |
0.0897 |
|
|
Body mass index |
(kg/m2) |
28.1±5.7 |
27.9±6.0 |
28.2±5.5 |
0.8507 |
|
|
(underweight) |
5 (8.5) |
3 (9.1) |
2 (7.7) |
0.8480 |
||
|
(normal weight) |
9 (15.3) |
5 (15.2) |
4 (15.4) |
0.9831 |
||
|
Corpulence status |
(overweight) |
22 (37.3) |
10 (30.3) |
12 (46.2) |
0.2099 |
|
|
(obesity) |
23 (39.0) |
15 (45.5) |
8 (30.8) |
0.2505 |
||
|
Comorbidities and passive smoking |
Arterial-hypertension |
(yes) |
14 (23.7) |
8 (24.2) |
6 (23.1) |
0.9214 |
|
Mellitus-diabetes |
(yes) |
10 (16.9) |
5 (15.2) |
5 (19.2) |
0.6844 |
|
|
Heart diseases |
(yes) |
8 (13.6) |
5 (15.2) |
3 (11.5) |
0.6803 |
|
|
Passive smoking |
(yes) |
11 (18.6) |
7 (21.2) |
4 (15.4) |
0.5701 |
|
|
Cough |
(yes) |
49 (83.1) |
28 (87.9) |
21 (80.8) |
0.4511 |
|
|
(grade 0) |
4 (6.8) |
0 (0.0) |
4 (15.4) |
0.0195 * |
||
|
(grade 1) |
22 (37.3) |
12 (36.4) |
10 (38.5) |
0.8685 |
||
|
Respiratory signs |
Dyspnea (modified medical research council) |
(grade 2) |
18 (30.5) |
13 (39.4) |
5 (19.2) |
0.0943 |
|
(grade 3) |
14 (23.7) |
8 (24.2) |
6 (23.1) |
0.9214 |
||
|
(grade 4) |
1 (1.7) |
0 (0.0) |
1 (3.8) |
0.2588 |
||
|
(score) |
1.8±1.0 |
1.9±0.8 |
1.6±1.1 |
0.2959 |
||
|
Duration of signs before RA diagnosis |
(months) |
137±173 |
106±160 |
176±183 |
0.1261 |
|
|
Extra-respiratory signs and symptoms |
Raynaud's phenomenon |
(yes) |
29 (49.2) |
15 (45.5) |
14 (53.8) |
0.5267 |
|
Morning stiffness |
(yes) |
51 (86.4) |
29 (87.9) |
22 (84.6) |
0.4511 |
|
|
Duration of signs before RA diagnosis |
(months) |
118±144 |
90±145 |
154±138 |
0.0944 |
|
|
RA activity |
DAS28-CRP |
(absolute value) |
6.00±1.02 |
6.04±0.86 |
5.94±1.21 |
0.7279 |
|
Disease activity status |
(severe) |
48 (81.4) |
28 (84.8) |
20 (76.9) |
0.4396 |
|
|
(moderate) |
11 (18.6) |
5 (15.2) |
6 (23.1) |
0.4396 |
ACPA: Anti-Citrullinated Peptides Antibodies. CRP: C-Reactive Protein. DAS28: Disease Activity Score 28. Quantitative and categorical data were mean±SD and number (%). *p-value < .05: 2 sided Chi-square test (comparison of categorical data between the 2 groups). Student's T test (comparison of quantitative data between the 2 groups).